Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Denali Therapeutics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 203
- −6 vs. Q1 2024
- Shares held
- 123.9M
- +3.03M (+2.5%) vs. Q1 2024
- Total value
- $2.88B
- +$396.3M (+16.0%) vs. Q1 2024
- New holders
- 29
- 84 more added
- Sold out
- 35
- 60 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 294 | $4.00B |
| Q1 2026 | 269 | $2.82B |
| Q4 2025 | 250 | $2.50B |
| Q3 2025 | 240 | $1.97B |
| Q2 2025 | 231 | $1.93B |
| Q1 2025 | 222 | $1.85B |
| Q4 2024 | 224 | $2.61B |
| Q3 2024 | 217 | $3.69B |
| Q2 2024 | 203 | $2.88B |
| Q1 2024 | 211 | $2.51B |
| Q4 2023 | 209 | $2.47B |
| Q3 2023 | 195 | $2.24B |
| Q2 2023 | 203 | $3.18B |
| Q1 2023 | 202 | $2.49B |
| Q4 2022 | 199 | $2.94B |
| Q3 2022 | 200 | $2.84B |
| Q2 2022 | 188 | $2.73B |
| Q1 2022 | 190 | $2.79B |
| Q4 2021 | 213 | $3.80B |
| Q3 2021 | 214 | $4.28B |
| Q2 2021 | 210 | $6.32B |
| Q1 2021 | 218 | $4.60B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Denali Therapeutics Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 11,312,439 | $262.7M | 0.01% | +344,146+3.1% | Added |
| BlackRock Inc. | 13,174,562 | $305.9M | 0.01% | +974,706+8.0% | Added |
| Baillie Gifford & Co | 13,763,596 | $319.6M | 0.25% | −277,632−2.0% | Reduced |
| Flagship Pioneering Inc. | 0 | $0 | 0.00% | −1,364,516−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −1,172,785−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −498,969−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −452,669−100.0% | Sold out |
| ARCH Venture Management, LLC | 0 | $0 | 0.00% | −381,249−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −209,613−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −177,364−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −112,118−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −69,314−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −58,847−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −50,500−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −47,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −42,288−100.0% | Sold out |
| EP Wealth Advisors, LLC | 0 | $0 | 0.00% | −40,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −37,749−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −34,085−100.0% | Sold out |
| University of Texas/Texas Am Investment Managment Co | 0 | $0 | 0.00% | −30,428−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −27,978−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −20,541−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −19,741−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −12,081−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,001−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,560−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −8,455−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −6,471−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,410−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −4,295−100.0% | Sold out |
| New Covenant Trust Company, N.A. | 0 | $0 | 0.00% | −784−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Naples Money Management LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |